ISLAMABAD: In a proactive measure to safeguard public health, the government has initiated comprehensive laboratory testing of the Avastin injection. The ongoing analysis includes a rigorous sterility test to ensure the highest standards of safety and quality.
Sources have confirmed that the Central Drug Laboratory in Karachi is spearheading the testing efforts, with a particular focus on the sterility of Avastin. Additionally, the lab is diligently examining the composition of Avastin, including its salt and formulation.
The significance of the sterility test cannot be overstated, as it plays a crucial role in confirming the absence of any infections in the medicine. In light of these developments, the sale and use of Avastin injection have been temporarily prohibited nationwide, and restrictions have been placed on its import and sale by the importer, AGC, and distributor, Roche Pharma.
Pending the laboratory report, Avastin injection sales will remain suspended to ensure the utmost safety for consumers. The government is committed to upholding the highest standards in pharmaceuticals and healthcare.
During a recent inspection of Roche Pharma's main warehouse in Karachi, the Drug Regulatory Authority of Pakistan (DRAP) collected samples of Avastin. It was discovered that Roche Pharma has a substantial stock of Avastin, comprising 793 Avastin injections of 100 ml across three batches.
The government's swift and thorough actions underscore its dedication to protecting public health and maintaining the integrity of the pharmaceutical industry. We will keep you updated as more information becomes available.
